Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report)’s share price dropped 4.4% during mid-day trading on Wednesday . The stock traded as low as $0.2056 and last traded at $0.2056. Approximately 228 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 936 shares. The stock had previously closed at $0.2150.
Zelira Therapeutics Stock Down 4.4%
The company has a fifty day moving average price of $0.22 and a two-hundred day moving average price of $0.25.
Zelira Therapeutics Company Profile
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Featured Articles
- Five stocks we like better than Zelira Therapeutics
- How to Invest in Biotech Stocks
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- The 3 Best Retail Stocks to Shop for in August
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- How to invest in marijuana stocks in 7 steps
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
